Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03612570 · ClinicalTrials.gov registry record · NA
Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia
A NA study, sponsored by Pulse Biosciences.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
NCT03612570 is a NA study that has completed, run by Pulse Biosciences. The registered enrollment target is 72 participants.
The verdict
NCT03612570, a NA study, has completed, sponsored by Pulse Biosciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
Study Summary
This prospective, open label, muti-center study evaluates the use of Nano-Pulse Stimulation (NPS) in the treatment of Sebaceous Hyperplasia (SH) lesions less than 2.5mm in size.
Interventions
- DEVICE Nano-Pulse Stimulation Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2018-06-28 |
| Est. Completion | 2018-11-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03612570
The ClinicalTrials.gov registry entry for NCT03612570 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pulse Biosciences, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nano-Pulse Stimulation Device is the first listed.
NCT03612570 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03612570 about?
NCT03612570 is a clinical study titled "Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia". This prospective, open label, muti-center study evaluates the use of Nano-Pulse Stimulation (NPS) in the treatment of Sebaceous Hyperplasia (SH) lesions less than 2.5mm in size.
What is the current status of trial NCT03612570?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2018-06-28. Estimated completion is 2018-11-28.
What interventions are being tested in trial NCT03612570?
The interventions under investigation include: Nano-Pulse Stimulation Device (DEVICE).
Who is sponsoring clinical trial NCT03612570?
This trial is sponsored by Pulse Biosciences, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.